Skip to main content
. 2019 Feb 27;8(5):e1581546. doi: 10.1080/2162402X.2019.1581546

Figure 3.

Figure 3.

Kaplan-Meier survival analysis of VISTA on the multi spot TMA (n = 165 patients). In both, surface (a) and infiltration zone (b) of the tumor, VISTA expression on tumor infiltrating T-cells (TILs) is correlated with superior overall survival compared to VISTA negative TILs. In subgroup analysis, the survival benefit of VISTA expression reveals in early invasive tumor stages (pT1/2 (c)) and is not detectable in advanced tumor stages (pT3/4 (d)). A difference in overall survival is also detectable in the validation cohort (e) which is predominantly driven by the survival difference in early tumor stages (pT1/2 (f)).